Laureano J. Rangel

Mayo Clinic in Arizona, WinnMed, Mayo Clinic in Florida

Papers

3

Total Citations

350

H-Index

3

About

Laureano J. Rangel is a leading biostatistician whose work has fundamentally shaped our understanding of surgical outcomes in urologic oncology, particularly for prostate cancer. His research focuses on comparative effectiveness, patient-reported outcomes, and the impact of patient-specific factors like obesity on surgical success. Rangel’s most influential contribution is his landmark 2008 study comparing open retropubic and robot-assisted radical prostatectomy, which has amassed over 270 citations and provided critical early evidence on the safety and oncological efficacy of robotic techniques. He further advanced the field by demonstrating how obesity significantly affects clinicopathologic outcomes following robot-assisted laparoscopic prostatectomy, a finding with over 45 citations that has informed preoperative counseling. In a notable 2015 study, Rangel shifted the focus to patient-centered care, analyzing functional outcomes from high-volume surgeons at high-volume hospitals. His rigorous statistical methodology has been instrumental in validating surgical innovations, making him a key figure in evidence-based urologic practice and a trusted collaborator at institutions like the Mayo Clinic.

Research Focus

Key Achievements

3
H-Index
3
Papers
350
Total Citations
117
Avg Citations/Paper
🏆 Most Cited Paper
Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot‐assisted techniques
271 citations · 2008
📈 Most Prolific Year: 2008 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Mayo Clinic in Arizona, WinnMed, Mayo Clinic in Florida

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago